MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5217.43M
Enterprise Value 397.68M
Trailing P/E N/A
Forward P/E 1-2.27
PEG Ratio (5 yr expected) 10.01
Price/Sales (ttm)6.88
Price/Book (mrq)N/A
Enterprise Value/Revenue 33.09
Enterprise Value/EBITDA 6-1.12

Trading Information

Stock Price History

Beta (3Y Monthly) 2.47
52-Week Change 3-63.36%
S&P500 52-Week Change 37.12%
52 Week High 39.2600
52 Week Low 32.0200
50-Day Moving Average 33.0447
200-Day Moving Average 35.1935

Share Statistics

Avg Vol (3 month) 3570.08k
Avg Vol (10 day) 3502.68k
Shares Outstanding 541.09M
Float 24.06M
% Held by Insiders 117.50%
% Held by Institutions 177.62%
Shares Short (Jun 28, 2019) 44.33M
Short Ratio (Jun 28, 2019) 44.27
Short % of Float (Jun 28, 2019) 439.33%
Short % of Shares Outstanding (Jun 28, 2019) 46.19%
Shares Short (prior month May 31, 2019) 46.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-300.72%

Management Effectiveness

Return on Assets (ttm)-44.60%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)31.62M
Revenue Per Share (ttm)0.77
Quarterly Revenue Growth (yoy)84.40%
Gross Profit (ttm)-67.69M
EBITDA -87.15M
Net Income Avi to Common (ttm)-95.36M
Diluted EPS (ttm)-2.3350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.6M
Total Cash Per Share (mrq)1.3
Total Debt (mrq)23.47M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.63
Book Value Per Share (mrq)-1.70

Cash Flow Statement

Operating Cash Flow (ttm)-68.48M
Levered Free Cash Flow (ttm)-45.67M